Aehr Test Systems Rebounds on AI Chip Fever, but Can a $59 Billion Revenue Company Justify a $3.9 Billion Valuation?

Shares shifted as Aehr Test Systems surged 6.7% to $101.56 on June 25, bouncing off a bruising slide from an all-time high of $123.26 just ten days ago. The catalyst: renewed enthusiasm for chip-equipment makers after Micron's blockbuster earnings report — Micron reported Q3 2026 earnings on June 24, injecting fresh life into the AI trade with strong results and an even stronger forecast — and continued investor excitement around Aehr's own record order backlog from hyperscale AI customers.

• A Single Customer Is Driving the Entire Growth Story. Aehr announced a record $41 million follow-on production order from its lead hyperscale customer for testing custom AI processor chips — the largest order in the company's history, supporting high-volume production of chips used in data center training and inference.

That brought second-half bookings past $92 million. This is powerful revenue visibility, but heavy reliance on one buyer makes the business fragile if that customer slows or switches suppliers.

• The Stock Price Has Far Outrun the Financials. Quarterly revenue sits near $10.3 million, with gross margin around 30.7%, while operating income is negative at about -$4.2 million.

Trailing annual revenue is roughly $59 million, yet the stock's price-to-sales ratio — a measure of how much investors pay per dollar of revenue — sits near 59.5 times.

Analysts do not expect the company to be profitable this year, and revenue declined 26% over the last twelve months. Investors are betting on a future that hasn't arrived yet.

• Fresh Cash Came With Dilution. On April 17, Aehr fully used its at-the-market equity program, raising roughly $60 million in gross proceeds by selling new shares into the open market. That bolsters the balance sheet for scaling up manufacturing, but it also means existing shareholders now own a smaller slice of the pie.

• Micron's Blowout Lifts All Chip Boats — For Now. Micron's revenue more than quadrupled in the fiscal third quarter, and its stock rose 15% in after-hours trading , creating a rising tide for semiconductor names like Aehr. Industry analysts project hyperscale-designed AI processor shipments will grow at a compound annual rate exceeding 30% through 2030. That's the wave Aehr is riding — but at nearly 60 times sales and with insiders recently selling millions in stock, the margin for disappointment is razor-thin.